Pages that link to "Q38015145"

The following pages link to Compound selection for in vitro modeling of developmental neurotoxicity (Q38015145):

Displaying 37 items.

• State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology (Q26852097) (← links)
• Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities (Q28388774) (← links)
• Prediction of developmental chemical toxicity based on gene networks of human embryonic stem cells (Q28831020) (← links)
• A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors (Q30662775) (← links)
• Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. (Q30835700) (← links)
• From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. (Q33794480) (← links)
• Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity (Q34361985) (← links)
• International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes (Q35024730) (← links)
• Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery (Q35137761) (← links)
• Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. (Q36456362) (← links)
• Stem Cell-Derived Immature Human Dorsal Root Ganglia Neurons to Identify Peripheral Neurotoxicants (Q36702996) (← links)
• Metabolomics in toxicology and preclinical research (Q37290233) (← links)
• Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay (Q37578338) (← links)
• Epigenetics and transcriptomics to detect adverse drug effects in model systems of human development. (Q38183159) (← links)
• Current approaches and future role of high content imaging in safety sciences and drug discovery (Q38229861) (← links)
• Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach (Q38319756) (← links)
• In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities (Q38753758) (← links)
• Nicotine exposure during differentiation causes inhibition of N-myc expression (Q39026893) (← links)
• Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods. (Q39247575) (← links)
• Transcriptomics in developmental toxicity testing (Q39336757) (← links)
• Recent developments in in vitro toxicology: perspectives of European research and Tox21. (Q43537123) (← links)
• Whole genome microarray analysis of neural progenitor C17.2 cells during differentiation and validation of 30 neural mRNA biomarkers for estimation of developmental neurotoxicity (Q47904486) (← links)
• Assessing neurodevelopmental effects of arsenolipids in pre-differentiated human neurons (Q48187874) (← links)
• Developmental neurotoxicity: the case of perfluoroalkylated compounds (Q48409169) (← links)
• Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity (Q50421707) (← links)
• Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods (Q50422052) (← links)
• Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. (Q50744606) (← links)
• Developmental neurotoxicity testing with human embryonic stem cell-derived in vitro systems: the novel FP7 ESNATS tests are available (Q50773442) (← links)
• Monocrotophos in Gandaman village: India school lunch deaths and need for improved toxicity testing (Q50782970) (← links)
• The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. (Q53135035) (← links)
• Teratogen screening with human pluripotent stem cells (Q57156286) (← links)
• Blood-brain barrier development: Systems modeling and predictive toxicology (Q89669447) (← links)
• Scanning laser optical tomography resolves developmental neurotoxic effects on pioneer neurons (Q89723019) (← links)
• Toxic Effects of Trichloroethylene on Rat Neuroprogenitor Cells (Q90454290) (← links)
• Use of stem cells as alternative methods to animal experimentation in predictive toxicology (Q92728096) (← links)
• Screening for Developmental Neurotoxicity at the National Toxicology Program: The Future Is Here (Q93368091) (← links)
• Advancing human health risk assessment (Q97073289) (← links)